In addition, Wuxi PharmaTech is a pharmaceutical R&D contract organization (CRO), which is often referred to as an enterprise providing R&D or production services for pharmaceutical companies. In recent years, under the wave of innovative drug research and development, enterprises of CRO, CMO and CDMO have mushroomed. WuXi PharmaTech, as the leader of CRO industry in China, has laid out the whole industrial chain of pharmaceutical R&D and production from drug discovery to clinical research to production.
Nantong Qidong Wuxi PharmaTech Biological Division:
Nantong Qidong medicine WuXi Kang Bio mainly provides related services for the discovery, development and production of macromolecular biopharmaceuticals. The core business of Wuxi Bio is not the same or similar to the main business of Wuxi PharmaTech. Independent operation and development, there is no horizontal competition.
As a listed company in Hong Kong, it is the world's leading open and integrated biopharmaceutical capability and technology empowerment platform. The company provides all-round end-to-end R&D services for biopharmaceutical companies and biotechnology companies around the world, helping anyone and any company to discover, develop and produce biopharmaceuticals, realizing the whole process from concept to commercial production, accelerating the global R&D process of biopharmaceuticals, reducing R&D costs and benefiting patients.